The U.S. hasn’t done enough to counter the use of technology transfers and supply chain infiltration from countries like China, according to two U.S. senators.

China’s plan to drive down generic drug prices through a centralized bulk procurement program is set to redraw the industry.

For the first time in almost two decades, Apple has lowered its revenue outlook — citing weakness in China’s economy and supply constraints.

The first quarter of 2019 will be pivotal, as the U.S. and China are trying to deescalate a trade war and Trump will have to decide whether to hit car imports with tariffs.

The U.S. may be exporting natural gas at a record clip, but that hasn’t stopped it from accepting new imports.

India’s new rules for foreign e-commerce platforms may be designed to protect local companies, but consumers are likely to suffer the collateral damage.